TapewireFind a company

person · Reporting owner

Wu Xiaobin

Disclosed activity across 1 company

Tapewire entity
18998
SEC CIK
0001739452

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
BeOne Medicines Ltd.ONC · Entity 2168President and COOAugust 25, 2026August 27, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

BeOne Medicines Ltd.

Report date August 25, 2026 · Filed August 27, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
American Depositary SharesSEC Table I · non-derivativeDirect0 Reported balance After 2026-08-25 transaction · row 4 Holding and transaction disclosures are not merged.
1 source row

Row 4 · 2026-08-25 · Sale · Disposed 280 · Balance 0

F1: Each American Depositary Share represents 13 Ordinary Shares.

F2: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025.

American Depositary SharesSEC Table I · non-derivativeDirect12,365 Reported balance Holding disclosure · report date 2026-08-25 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 12,365

F1: Each American Depositary Share represents 13 Ordinary Shares.

Ordinary SharesSEC Table I · non-derivativeDirect1,270,084 Reported balance Holding disclosure · report date 2026-08-25 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 1,270,084

American Depositary SharesSEC Table I · non-derivativeIndirectBy Wife4,000 Reported balance Holding disclosure · report date 2026-08-25 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 4,000

F1: Each American Depositary Share represents 13 Ordinary Shares.

Filing footnotes · ownership attribution and instrument terms

F1: Each American Depositary Share represents 13 Ordinary Shares.

F2: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 17, 2024 Filed Jun 20, 2024 21:25 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 627 $159.00 $99,691.81
Disclosure

SEC source: 0001651308-24-000072 · wk-form4_1718918703.xml · nonDerivative · entry 5

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,627

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F6 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.885 to $159.2191, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:04 UTC BeOne Medicines Ltd. BGNE · Entity 2168 GrantShare Option (Right to Buy) · Derivative 477,386 $0.00 Strike: $12.23 $0.00
Disclosure

SEC source: 0001651308-24-000068 · wk-form4_1717794275.xml · derivative · entry 5

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 477,386

Underlying: Ordinary Shares · 477,386 shares

Expires 2034-06-04

F7 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.

F7 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.

F8 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:04 UTC BeOne Medicines Ltd. BGNE · Entity 2168 GrantOrdinary Shares 253,409 $0.00 $0.00
Disclosure

SEC source: 0001651308-24-000068 · wk-form4_1717794275.xml · nonDerivative · entry 1

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,268,849

F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

F2 · balance_after: Includes 1,443 ordinary shares acquired pursuant to the Company's Third Amended and Restated 2018 Employee Share Purchase Plan.

Read SEC document
June 26, 2023 Filed Jun 27, 2023 21:20 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 1,495 $182.37 $272,635.68
Disclosure

SEC source: 0001651308-23-000100 · wf-form4_168790078913526.xml · nonDerivative · entry 5

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F5 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

Read SEC document
June 20, 2023 Filed Jun 20, 2023 22:49 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 1,753 $192.44 $337,355.91
Disclosure

SEC source: 0001651308-23-000090 · wf-form4_168730136898919.xml · nonDerivative · entry 5

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F6 · kind: The sale was effected pursuant to mandatory tax withholding provisions in the Reporting Person's restricted share unit award agreements in connection with the vesting of two restricted share unit awards previously granted to the Reporting Person. 1/4th of the securities under one award will vest on each anniversary of June 17, 2020 and under the other award on each anniversary June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.41 to $192.61, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
June 15, 2023 Filed Jun 20, 2023 22:49 UTC BeOne Medicines Ltd. BGNE · Entity 2168 GrantShare Option (Right to Buy) · Derivative 760,851 $0.00 Strike: $16.41 $0.00
Disclosure

SEC source: 0001651308-23-000090 · wf-form4_168730136898919.xml · derivative · entry 6

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 760,851

Underlying: Ordinary Shares · 760,851 shares

Expires 2033-06-14

F8 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.

F8 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.

F9 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control.

Read SEC document
June 15, 2023 Filed Jun 20, 2023 22:49 UTC BeOne Medicines Ltd. BGNE · Entity 2168 GrantOrdinary Shares 200,447 $0.00 $0.00
Disclosure

SEC source: 0001651308-23-000090 · wf-form4_168730136898919.xml · nonDerivative · entry 1

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,033,432

F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 21:44 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 824 $226.15 $186,348.51
Disclosure

SEC source: 0001651308-23-000078 · wf-form4_168634706406225.xml · nonDerivative · entry 8

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F5 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.835 to $226.62, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 21:44 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 789 $225.27 $177,739.69
Disclosure

SEC source: 0001651308-23-000078 · wf-form4_168634706406225.xml · nonDerivative · entry 7

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 824

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F5 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.81 to $225.80, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 21:44 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 1,147 $224.04 $256,974.22
Disclosure

SEC source: 0001651308-23-000078 · wf-form4_168634706406225.xml · nonDerivative · entry 6

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,613

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F5 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.71 to $224.67, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 21:44 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 531 $223.23 $118,536.88
Disclosure

SEC source: 0001651308-23-000078 · wf-form4_168634706406225.xml · nonDerivative · entry 5

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,760

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F5 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.625 to $223.53, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price.

Read SEC document
May 08, 2023 Filed May 10, 2023 20:44 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 7,000 $253.72 $1,776,037.20
Disclosure

SEC source: 0001651308-23-000073 · wf-form4_168375144660771.xml · nonDerivative · entry 5

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F6 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.65 to $253.94, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price.

Read SEC document
June 22, 2022 Filed Jun 24, 2022 21:39 UTC BeOne Medicines Ltd. BGNE · Entity 2168 GrantShare Option (Right to Buy) · Derivative 1,061,814 $0.00 Strike: $11.98 $0.00
Disclosure

SEC source: 0001651308-22-000111 · wf-form4_165610676599580.xml · derivative · entry 5

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,061,814

Underlying: Ordinary Shares · 1,061,814 shares

Expires 2032-06-21

F6 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F6 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F7 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 22, 2022, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control.

Read SEC document
June 22, 2022 Filed Jun 24, 2022 21:39 UTC BeOne Medicines Ltd. BGNE · Entity 2168 GrantOrdinary Shares 187,876 $0.00 $0.00
Disclosure

SEC source: 0001651308-22-000111 · wf-form4_165610676599580.xml · nonDerivative · entry 1

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 987,867

F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

Read SEC document
June 21, 2022 Filed Jun 22, 2022 21:45 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 1,010 $144.36 $145,803.70
Disclosure

SEC source: 0001651308-22-000090 · wf-form4_165593431479531.xml · nonDerivative · entry 6

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 17, 2020, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.28 to $144.555, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
June 17, 2022 Filed Jun 22, 2022 21:45 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 578 $139.60 $80,691.11
Disclosure

SEC source: 0001651308-22-000090 · wf-form4_165593431479531.xml · nonDerivative · entry 5

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,010

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F5 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.54 to $139.91, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 21:42 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 3,410 $141.99 $484,201.59
Disclosure

SEC source: 0001651308-22-000079 · wf-form4_165472451863399.xml · nonDerivative · entry 5

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F5 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.80 to $142.26, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
May 05, 2022 Filed May 6, 2022 21:15 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 500 $169.39 $84,693.50
Disclosure

SEC source: 0001651308-22-000067 · wf-form4_165187169476462.xml · nonDerivative · entry 11

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F5 · security: Each American Depositary Share represents 13 Ordinary Shares.

F6 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.265 to $169.44, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price.

Read SEC document
May 05, 2022 Filed May 6, 2022 21:15 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 100 $168.15 $16,814.50
Disclosure

SEC source: 0001651308-22-000067 · wf-form4_165187169476462.xml · nonDerivative · entry 10

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500

F5 · security: Each American Depositary Share represents 13 Ordinary Shares.

F6 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

Read SEC document
May 05, 2022 Filed May 6, 2022 21:15 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 700 $167.32 $117,121.97
Disclosure

SEC source: 0001651308-22-000067 · wf-form4_165187169476462.xml · nonDerivative · entry 9

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600

F5 · security: Each American Depositary Share represents 13 Ordinary Shares.

F6 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.00 to $167.75, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price.

Read SEC document
May 05, 2022 Filed May 6, 2022 21:15 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 1,100 $165.07 $181,577.55
Disclosure

SEC source: 0001651308-22-000067 · wf-form4_165187169476462.xml · nonDerivative · entry 8

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,300

F5 · security: Each American Depositary Share represents 13 Ordinary Shares.

F6 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.7434 to $165.565, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price.

Read SEC document
May 05, 2022 Filed May 6, 2022 21:15 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 175 $165.02 $28,878.96
Disclosure

SEC source: 0001651308-22-000067 · wf-form4_165187169476462.xml · nonDerivative · entry 7

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,400

F5 · security: Each American Depositary Share represents 13 Ordinary Shares.

F6 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.01 to $165.11, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price.

Read SEC document
May 05, 2022 Filed May 6, 2022 21:15 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 3,350 $163.23 $546,813.80
Disclosure

SEC source: 0001651308-22-000067 · wf-form4_165187169476462.xml · nonDerivative · entry 6

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,575

F5 · security: Each American Depositary Share represents 13 Ordinary Shares.

F6 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.79 to $163.625, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
May 05, 2022 Filed May 6, 2022 21:15 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 800 $161.72 $129,375.52
Disclosure

SEC source: 0001651308-22-000067 · wf-form4_165187169476462.xml · nonDerivative · entry 5

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,925

F5 · security: Each American Depositary Share represents 13 Ordinary Shares.

F6 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.10 to $161.99, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price.

Read SEC document
December 15, 2021 Filed Dec 17, 2021 22:03 UTC BeOne Medicines Ltd. BGNE · Entity 2168 GrantRMB Shares 0 $30.13 $0.00
Disclosure

SEC source: 0001651308-21-000262 · wf-form4_163977857333996.xml · nonDerivative · entry 1

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

F1 · security: The term "RMB Shares" is used herein to represent the ordinary shares, par value $0.0001 per share, of the Issuer, issued directly by the Issuer in the Issuer's initial public offering on the Science and Technology Innovation Board (the "STAR Market") of the Shanghai Stock Exchange (the "STAR Offering"), to permitted investors in Renminbi ("RMB") within the People's Republic of China ("PRC") in accordance with the rules of the STAR Market.

F2 · kind: The Issuer established an employee participation program ("RMB Shares Employee Participation Plan"), which allows certain executive officers and qualified employees of the Issuer's subsidiaries in the PRC to indirectly participate in the STAR Offering and purchase certain RMB Shares from the Issuer through an asset management plan administrated by China International Capital Corporation Limited in a transaction that is exempt under Rule 16b-3. The RMB Share Employee Participation Plan purchased an aggregate of 2,069,546 RMB Shares directly from the Issuer in the STAR Offering at the initial public offering price of RMB192.6 per RMB Share (or $30.1295 based on an assumed exchange rate of $1.00 = RMB6.3924).

F3 · kind: The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, has contributed RMB15 million to the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose.

F2 · shares: The Issuer established an employee participation program ("RMB Shares Employee Participation Plan"), which allows certain executive officers and qualified employees of the Issuer's subsidiaries in the PRC to indirectly participate in the STAR Offering and purchase certain RMB Shares from the Issuer through an asset management plan administrated by China International Capital Corporation Limited in a transaction that is exempt under Rule 16b-3. The RMB Share Employee Participation Plan purchased an aggregate of 2,069,546 RMB Shares directly from the Issuer in the STAR Offering at the initial public offering price of RMB192.6 per RMB Share (or $30.1295 based on an assumed exchange rate of $1.00 = RMB6.3924).

F3 · shares: The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, has contributed RMB15 million to the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose.

F2 · acquired: The Issuer established an employee participation program ("RMB Shares Employee Participation Plan"), which allows certain executive officers and qualified employees of the Issuer's subsidiaries in the PRC to indirectly participate in the STAR Offering and purchase certain RMB Shares from the Issuer through an asset management plan administrated by China International Capital Corporation Limited in a transaction that is exempt under Rule 16b-3. The RMB Share Employee Participation Plan purchased an aggregate of 2,069,546 RMB Shares directly from the Issuer in the STAR Offering at the initial public offering price of RMB192.6 per RMB Share (or $30.1295 based on an assumed exchange rate of $1.00 = RMB6.3924).

F3 · acquired: The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, has contributed RMB15 million to the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose.

F2 · balance_after: The Issuer established an employee participation program ("RMB Shares Employee Participation Plan"), which allows certain executive officers and qualified employees of the Issuer's subsidiaries in the PRC to indirectly participate in the STAR Offering and purchase certain RMB Shares from the Issuer through an asset management plan administrated by China International Capital Corporation Limited in a transaction that is exempt under Rule 16b-3. The RMB Share Employee Participation Plan purchased an aggregate of 2,069,546 RMB Shares directly from the Issuer in the STAR Offering at the initial public offering price of RMB192.6 per RMB Share (or $30.1295 based on an assumed exchange rate of $1.00 = RMB6.3924).

F3 · balance_after: The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, has contributed RMB15 million to the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose.

F3 · ownership.nature: The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, has contributed RMB15 million to the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose.

Read SEC document
November 09, 2021 Filed Nov 10, 2021 22:14 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 100 $375.00 $37,500.00
Disclosure

SEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 25

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021.

Read SEC document
November 09, 2021 Filed Nov 10, 2021 22:14 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 200 $373.58 $74,716.00
Disclosure

SEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 24

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021.

Read SEC document
November 09, 2021 Filed Nov 10, 2021 22:14 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 200 $371.76 $74,352.00
Disclosure

SEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 23

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021.

Read SEC document
November 09, 2021 Filed Nov 10, 2021 22:14 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 100 $369.98 $36,998.00
Disclosure

SEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 22

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021.

Read SEC document
November 09, 2021 Filed Nov 10, 2021 22:14 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 300 $367.10 $110,129.82
Disclosure

SEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 21

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021.

F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $367.04 to $367.21, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 09, 2021 Filed Nov 10, 2021 22:14 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 200 $365.93 $73,185.00
Disclosure

SEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 20

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 900

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021.

Read SEC document
November 09, 2021 Filed Nov 10, 2021 22:14 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 485 $364.19 $176,632.88
Disclosure

SEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 19

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,100

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021.

F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $363.81 to $364.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 09, 2021 Filed Nov 10, 2021 22:14 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 449 $363.15 $163,055.56
Disclosure

SEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 18

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,585

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021.

F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.71 to $363.68, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 09, 2021 Filed Nov 10, 2021 22:14 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 300 $361.56 $108,468.99
Disclosure

SEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 17

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,034

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021.

F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $361.38 to $361.655, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 08, 2021 Filed Nov 10, 2021 22:14 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 100 $361.03 $36,103.00
Disclosure

SEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 16

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021.

Read SEC document
November 08, 2021 Filed Nov 10, 2021 22:14 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 4,433 $360.08 $1,596,221.78
Disclosure

SEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 15

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021.

F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $359.94 to $360.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 08, 2021 Filed Nov 10, 2021 22:14 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 200 $358.59 $71,718.00
Disclosure

SEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 14

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,533

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021.

Read SEC document
November 08, 2021 Filed Nov 10, 2021 22:14 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 300 $355.32 $106,595.01
Disclosure

SEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 13

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,733

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021.

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $354.92 to $355.59, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 08, 2021 Filed Nov 10, 2021 22:14 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 300 $354.03 $106,208.01
Disclosure

SEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 12

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,033

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.92 to $354.20, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 08, 2021 Filed Nov 10, 2021 22:14 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 100 $352.76 $35,276.00
Disclosure

SEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 11

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,333

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021.

Read SEC document
November 08, 2021 Filed Nov 10, 2021 22:14 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 300 $351.28 $105,383.01
Disclosure

SEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 10

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,433

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.13 to $351.57, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 08, 2021 Filed Nov 10, 2021 22:14 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 164 $349.66 $57,344.26
Disclosure

SEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 9

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,733

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $349.36 to $350.27, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 08, 2021 Filed Nov 10, 2021 22:14 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 449 $348.70 $156,567.11
Disclosure

SEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 8

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,897

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $348.25 to $348.90, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 08, 2021 Filed Nov 10, 2021 22:14 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 420 $347.20 $145,826.02
Disclosure

SEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 7

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,346

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $347.05 to $347.38, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 08, 2021 Filed Nov 10, 2021 22:14 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 300 $346.43 $103,929.00
Disclosure

SEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 6

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,766

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $346.05 to $347.00, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 08, 2021 Filed Nov 10, 2021 22:14 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 300 $345.06 $103,518.99
Disclosure

SEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 5

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,066

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $345.01 to $345.17, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
November 08, 2021 Filed Nov 10, 2021 22:14 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 300 $343.12 $102,935.01
Disclosure

SEC source: 0001651308-21-000224 · wf-form4_163658242455284.xml · nonDerivative · entry 4

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,366

F2 · security: Each American Depositary Share represents 13 Ordinary Shares.

F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2021.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $342.80 to $343.75, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price.

Read SEC document
July 06, 2021 Filed Jul 8, 2021 22:25 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 100 $331.88 $33,188.00
Disclosure

SEC source: 0001651308-21-000149 · wf-form4_162578307197535.xml · nonDerivative · entry 11

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2020.

Read SEC document
July 06, 2021 Filed Jul 8, 2021 22:25 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 100 $329.60 $32,959.53
Disclosure

SEC source: 0001651308-21-000149 · wf-form4_162578307197535.xml · nonDerivative · entry 10

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2020.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $329.57 to $330.00, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
July 06, 2021 Filed Jul 8, 2021 22:25 UTC BeOne Medicines Ltd. BGNE · Entity 2168 SaleAmerican Depositary Shares 1,000 $328.19 $328,190.60
Disclosure

SEC source: 0001651308-21-000149 · wf-form4_162578307197535.xml · nonDerivative · entry 9

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2020.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $327.81 to $328.76, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.